company background image
FLRY3 logo

Fleury BOVESPA:FLRY3 Rapporto sulle azioni

Ultimo prezzo

R$13.54

Cap. di mercato

R$7.5b

7D

-3.0%

1Y

-20.6%

Aggiornato

18 Nov, 2024

Dati

Dati finanziari dell'azienda +

Fleury S.A.

BOVESPA:FLRY3 Rapporto sulle azioni

Cap. di mercato: R$7.5b

FLRY3 Panoramica delle azioni

Fleury S.A., insieme alle sue controllate, fornisce servizi medici nei settori della diagnostica, del trattamento, dell'analisi clinica, della gestione della salute, dell'assistenza medica, dell'ortopedia e dell'oftalmologia in Brasile. Maggiori dettagli

FLRY3 analisi fondamentale
Punteggio fiocco di neve
Valutazione5/6
Crescita futura2/6
Prestazioni passate5/6
Salute finanziaria4/6
Dividendi4/6

Premi

Negoziato a 36.3% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 13.82% all'anno

Gli utili sono cresciuti del 64.3% nell'ultimo anno

Gli analisti concordano sul fatto che il prezzo delle azioni salirà di 41%

Analisi del rischio

Andamento instabile dei dividendi


Fleury S.A. Concorrenti

Oncoclínicas do Brasil Serviços Médicos

BOVESPA:ONCO3

R$2.5b

Odontoprev

BOVESPA:ODPV3

R$5.6b

Rede D'Or São Luiz

BOVESPA:RDOR3

R$66.1b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$864.4m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Fleury
Prezzi storici delle azioni
Prezzo attuale dell'azioneR$13.54
Massimo di 52 settimaneR$18.96
Minimo di 52 settimaneR$13.46
Beta0.60
1Variazione di 1 mese-9.25%
Variazione a 3 mesi-14.52%
Variazione di 1 anno-20.63%
3Variazione a 3 anni-24.01%
Variazione a 5 anni-50.06%
Variazione dall'IPO55.80%

Notizie e aggiornamenti recenti

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Rendimenti per gli azionisti

FLRY3BR HealthcareBR Mercato
7D-3.0%0.3%-0.06%
1Y-20.6%-13.6%-1.6%

Ritorno vs Industria: FLRY3 ha avuto una performance inferiore rispetto al BR Healthcare che ha registrato un rendimento -13.6 % nell'ultimo anno.

Rendimento vs Mercato: FLRY3 ha avuto una performance inferiore al mercato BR che ha registrato un rendimento -1.6 % nell'ultimo anno.

Volatilità dei prezzi

Is FLRY3's price volatile compared to industry and market?
FLRY3 volatility
FLRY3 Average Weekly Movement3.1%
Healthcare Industry Average Movement6.1%
Market Average Movement4.5%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.3%

Prezzo delle azioni stabile: FLRY3 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 3% ) di FLRY3 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
192627,000Jeane Tsutsuiri.fleury.com.br

Fleury S.A., insieme alle sue controllate, fornisce servizi medici nei settori della diagnostica, del trattamento, delle analisi cliniche, della gestione della salute, dell'assistenza medica, dell'ortopedia e dell'oftalmologia in Brasile. L'azienda opera attraverso tre segmenti: Medicina diagnostica, Medicina integrata e Odontoiatria. Fornisce test di laboratorio e di imaging, genomica, gestione della salute e piattaforma, informazioni diagnostiche, check-up e laboratorio di riferimento, day hospital, centro infusionale, ortopedia e oftalmologia, test di imaging dentale e servizi di imaging diagnostico.

Fleury S.A. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Fleury con la sua capitalizzazione di mercato?
FLRY3 statistiche fondamentali
Capitalizzazione di mercatoR$7.49b
Guadagni(TTM)R$613.53m
Ricavi(TTM)R$7.55b

12.0x

Rapporto P/E

1.0x

Rapporto P/S

FLRY3 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
FLRY3 Conto economico (TTM)
RicaviR$7.55b
Costo del fatturatoR$5.46b
Profitto lordoR$2.09b
Altre speseR$1.48b
GuadagniR$613.53m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)1.13
Margine lordo27.69%
Margine di profitto netto8.13%
Rapporto debito/patrimonio netto71.2%

Come si è comportato FLRY3 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

4.3%

Rendimento attuale del dividendo

13%

Rapporto di remunerazione